This report provides comprehensive information on the therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nicotine Addiction and special features on late-stage and discontinued projects. http://www.researchmoz.us/nicotine-addiction-pipeline-review-h1-2015-report.html

1. Nicotine Addiction - Pipeline Review, H1 2015
Global Markets Directs, Nicotine Addiction Pipeline Review, H1 2015, provides an overview of the Nicotine Addictions therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the therapeutic development for Nicotine Addiction and special features on late-stage and
discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Nicotine Addiction The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players
involved in the therapeutics development for Nicotine Addiction and enlists all their major and minor projects The report summarizes all the dormant and
discontinued pipeline projects A review of the Nicotine Addiction products under development by companies and universities/research institutes based on
information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from
pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Nicotine
Addiction pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the
focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Nicotine Addiction Plan mergers
and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Nicotine
Addiction pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline
table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
global Markets Direct Report Coverage 6
nicotine Addiction Overview 7
therapeutics Development 8
pipeline Products For Nicotine Addiction - Overview 8
pipeline Products For Nicotine Addiction - Comparative Analysis 9
nicotine Addiction - Therapeutics Under Development By Companies 10
nicotine Addiction - Therapeutics Under Investigation By Universities/institutes 11
nicotine Addiction - Pipeline Products Glance 12
clinical Stage Products 12
early Stage Products 13
nicotine Addiction - Products Under Development By Companies 14
nicotine Addiction - Products Under Investigation By Universities/institutes 15
nicotine Addiction - Companies Involved In Therapeutics Development 16
abbvie Inc. 16
astraea Therapeutics, Llc 17
embera Neurotherapeutics, Inc. 18
forum Pharmaceuticals Inc. 19
heptares Therapeutics Ltd. 20
omeros Corporation 21
nicotine Addiction - Therapeutics Assessment 22
assessment By Monotherapy Products 22
assessment By Combination Products 23
assessment By Target 24
assessment By Mechanism Of Action 26
assessment By Route Of Administration 28
Nicotine Addiction - Pipeline Review, H1 2015

2. assessment By Molecule Type 29
drug Profiles 31
(oxazepam + Metyrapone) - Drug Profile 31
product Description 31
mechanism Of Action 31
r&d Progress 31
at-1001 - Drug Profile 33
product Description 33
mechanism Of Action 33
r&d Progress 33
drugs To Inhibit Faah For Cns Disorders - Drug Profile 34
product Description 34
mechanism Of Action 34
r&d Progress 34
encenicline Hydrochloride - Drug Profile 35
product Description 35
mechanism Of Action 35
r&d Progress 35
oms-405 - Drug Profile 38
product Description 38
mechanism Of Action 38
r&d Progress 38
oms-527 - Drug Profile 39
product Description 39
mechanism Of Action 39
r&d Progress 39
slv-330 - Drug Profile 41
product Description 41
mechanism Of Action 41
r&d Progress 41
small Molecule To Antagonize Orexin 1 For Addiction And Compulsive Disorders - Drug Profile 42
product Description 42
mechanism Of Action 42
r&d Progress 42
small Molecules To Inhibit Dopamine Transporter For Cns And Metabolic Disorders - Drug Profile 43
product Description 43
mechanism Of Action 43
r&d Progress 43
vaccine For Nicotine Addiction - Drug Profile 44
product Description 44
mechanism Of Action 44
r&d Progress 44
vaccine For Nicotine Addiction - Drug Profile 45
product Description 45
mechanism Of Action 45
r&d Progress 45
nicotine Addiction - Recent Pipeline Updates 46
nicotine Addiction - Dormant Projects 50
nicotine Addiction - Discontinued Products 51
nicotine Addiction - Product Development Milestones 52
featured News & Press Releases 52
mar 19, 2013: Omeros Elucidates Mechanism Of Pde7 Inhibitors In Addiction 52
may 05, 2011: Omeros Announces Expansion Of Potential Indications For Pde7 Inhibitors 52
appendix 54
methodology 54
coverage 54
secondary Research 54
primary Research 54
expert Panel Validation 54
contact Us 54
disclaimer 55
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Nicotine Addiction - Pipeline Review, H1 2015

3. Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Nicotine Addiction - Pipeline Review, H1 2015